Skip to main content
SpringerLink
Log in

Pharmacokinetics of Drugs in Obesity

  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

Pharmacokinetic data in obesity are only available for a limited number of drugs. The rate or extent of drug absorption is not known to be altered by obesity which is not complicated by other medical disease. In contrast, drug distribution is in some instances significantly altered in obesity. Digoxin and bromsulphalein, both hydrophilic drugs, do not distribute into excess bodyweight over ideal bodyweight. However, antipyrine, paracetamol, aminoglycoside antibiotics and theophylline, all of intermediate lipid solubility, distribute to a limited extent into excess bodyweight over ideal bodyweight, although not as extensively as into ideal bodyweight. Benzodiazepines, halothane and enflurane, highly lipophilic agents, may distribute much more extensively into excess bodyweight over ideal bodyweight than into ideal bodyweight. This suggests some relationship between drug distribution and drug lipid-solubility in obese subjects. Whether these distributional changes in obesity will hold for other drugs is not currently known.

Drug protein binding has not been demonstrated to be changed in obesity, data being presently available only for the basic drugs diazepam and desmethyldiazepam.

Drug biotransformation in obesity is unchanged for oxidatively metabolised drus studied to date. Paracetamol, the only metabolised drug which is conjugated for which pharmacokinetic parameters have been accurately determined in obesity, undergoes increased clearance in obese subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abernethy, D.R.; Greenblatt, U.J.; Divoll, M.; Harmatz, J.S. and Shader, R.I.: Alterations in drug distribution and clearance due to obesity. Journal of Pharmacology and Experimental Therapeutics 217: 681–685 (1981a).

    PubMed  CAS  Google Scholar 

  • Abernethy, D.R.; Greenblatt, D.J. and Zumbo, A.M.: Antipyrine determination in human plasma by gas-liquid chromatography using nitrogen-phosphorous detection. Journal of Chromatography 223: 432–437 (1981b).

    Article  PubMed  CAS  Google Scholar 

  • Abernethy, D.R.; Greenblatt, D.J. and Smith, T.W.: Digoxin disposition in obesity: Clinical pharmacokinetic investigation. American Heart Journal 102: 740–744 (1981c).

    Article  PubMed  CAS  Google Scholar 

  • Abernethy, D.R.; Divoll, M.; Ameer, B. and Greenblatt, D.J.: Acetaminophen kinetics in obesity. Clinical Pharmacology and Therapeutics 29: 230 (1981d).

    Article  Google Scholar 

  • Abernethy, D.R.; Divoll, M.; Greenblatt, D.J. and Ameer, B.: Effect of obesity and sex on acetaminophen disposition. Submitted for publication (1981e).

  • Abernethy, D.R.; Greenblatt, D.J. and Divoll, M.: Desmethyl-diazepam kinetics in obesity. Journal of Pharmaceutical Sciences. In press (1981f).

  • Abraham, S. and Johnson, C.L.: Prevalence of severe obesity in adults in the United States. American Journal of Clinical Nutrition 33: 364–369 (1980).

    PubMed  CAS  Google Scholar 

  • Adler, M. and Schaffner, F.: Fatty liver hepatitis and cirrhosis in obese patients. American Journal of Medicine 67: 811–816 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Alexander, J.K.; Dennis, E.W. and Smith, W.G.: Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity. Cardiovascular Center Research Bulletin 1: 39–44 (1962-1963).

    Google Scholar 

  • Alvares, A.P.; Anderson, K.E.; Conney, A.H. and Kappas, A.: Interactions between nutritional factors and drug biotransformations in man. Proceedings of the National Academy of Sciences (USA) 73: 2501–2504 (1976).

    Article  CAS  Google Scholar 

  • Anderson, K.E.; Conney, A.H. and Kappas, A.: Nutrition and oxidative drug metabolism in man: Relative influence of dietary lipids, carbohydrate, and protein. Clinical Pharmacology and Therapeutics 26: 493–501 (1979).

    PubMed  CAS  Google Scholar 

  • Bauer, L.A.; Blouin, R.A.; Griffen, W.O.; Record, K.E. and Bell, R.M.: Amikacin pharmacokinetics in morbidly obese patients. American Journal of Hospital Pharmacy 37: 519–522 (1980).

    PubMed  CAS  Google Scholar 

  • Berkowitz, D.: Metabolic changes associated with obesity before and after weight reduction. Journal of the American Medical Association 187: 399–403 (1964).

    Article  PubMed  CAS  Google Scholar 

  • Blouin, R.A.; Mann, H.J.; Griffen, W.O.; Bauer, L.A. and Record, K.E.: Tobramycin pharmacokinetics in morbid obesity. Clinical Pharmacology and Therapeutics 26: 508–512 (1979).

    PubMed  CAS  Google Scholar 

  • Blouin, R.A.; Elgert, J.F. and Bauer, L.A.: Theophylline clearance: Effect of marked obesity. Clinical Pharmacology and Therapeutics 28: 619–623 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Boxenbaum, H.G.; Riegelman, S. and Elashoff, R.M.: Statistical estimations in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 2: 123–148 (1974).

    PubMed  CAS  Google Scholar 

  • Bray, G.A.: Obesity. Disease-a-Month 26 (October): 7–83 (1979).

    Article  Google Scholar 

  • Bray, G.A.; Davidson, M.B. and Drenick, E.J.: Obesity: A serious symptom. Annals of Internal Medicine 77: 797–805 (1972).

    Google Scholar 

  • Brodie, B.B.; Axelrod, J.; Soberman, R. and Levy, B.B.: The estimation of antipyrine in biological materials. Journal of Biological Chemistry 179: 25–29 (1949).

    PubMed  CAS  Google Scholar 

  • Cummings, A.J.; King, M.L. and Martin, B.K.: A kinetic study of drug elimination: The excretion of paracetamol and its metabolites in man. British Journal of Pharmacology and Chemotherapeutics 29: 15–157 (1967).

    Google Scholar 

  • Dano, P.; Nielsen, O.; Petri, M. and Jorgensen, B.: Liver morphology and liver function before and after intestinal shunt operation for obesity. Scandinavian Journal of Gastroenterology 10: 409–416 (1975).

    PubMed  CAS  Google Scholar 

  • Devine, B.J.: Gentamicin therapy. Drug Intelligence and Clinical Pharmacy 8: 650–655 (1974).

    Google Scholar 

  • Diem, K. and Lentner, C.: Documenta Geigy, Scientific Tables, p.712 (Geigy, Basel 1970).

    Google Scholar 

  • Doherty, J.E.; Perkins, W.H. and Flanigan, W.J.: The distribution and concentration of tritiated digoxin in human tissues. Annals of Internal Medicine 66: 116–124 (1967).

    PubMed  CAS  Google Scholar 

  • Ewy, G.A.; Groves, B.M.; Ball, M.F.; Nimmo, L.; Jackson, B. and Marcus, F.: Digoxin metabolism in obesity. Circulation 44: 810–814 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Freston, J.W. and Englert, E.: The influence of age and excessive body weight on the distribution and metabolism of bromsulphalein. Clinical Sciences 33: 301–312 (1967).

    CAS  Google Scholar 

  • Gal, P.; Jusko, W.J.; Yurchak, A.M. and Franklin, B.A.: Theophylline disposition in obesity. Clinical Pharmacology and Therapeutics 23: 438–444 (1978).

    PubMed  CAS  Google Scholar 

  • Greenblatt, D.J.: Simultaneous gas chromatographic analysis for diazepam and its major metabolite, desmethyldiazepam, with use of double internal standardization. Clinical Chemistry 24: 1838–1841 (1978).

    PubMed  CAS  Google Scholar 

  • Greenblatt, D.J. and Locniskar, A.: Spectrophotometric assay of antipyrine in plasma: A re-evaluation. International Journal of Clinical pharmacology and Biopharmacy 17: 401–404 (1979).

    PubMed  CAS  Google Scholar 

  • Hankin, M.E.; Munz, K. and Steinbeck, A.W.: Total body water content in normal and obese women. Medical Journal of Australia 2: 533 (1976).

    PubMed  CAS  Google Scholar 

  • Harrison, C.E.; Bradenburg, R.O.; Ongley, P.A.; Orvis, A.L. and Owens, C.A., Jr: Distribution and excretion of tritiated substances in experimental animals following the administration of digoxin-3H. Journal of Laboratory and Clinical Medicine 67: 764–776 (1966).

    PubMed  CAS  Google Scholar 

  • Jusko, W.J. and Weintraub, M.: Myocardial distribution of digoxin and renal function. Clinical Pharmacology and Therapeutics 16: 449–454 (1974).

    PubMed  CAS  Google Scholar 

  • Jusko, W.J.; Gardner, M.J.; Mangione, A.; Schentag, J.J.; Koup, J.R. and Vance, J.W.: Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol. Journal of Pharmaceutical Sciences 68: 1358–1366 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Kappas, A.; Anderson, K.E.; Conney, A.H. and Alvares, A.P.: Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man. Clinical Pharmacology and Therapeutics 20: 643–653 (1976).

    PubMed  CAS  Google Scholar 

  • Korsager, S.: Administration of gentamicin to obese patients. International Journal of Clinical Pharmacology, Therapy, and Toxicology 18: 549–553 (1980).

    PubMed  CAS  Google Scholar 

  • Loo, J.C.K. and Riegelman, S.: Assessment of pharmacokinetic constants from post-infusion blood curves obtained after i.v. infusion. Journal of Pharmaceutical Sciences 59: 53–55 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Lowenthal, D.T.; Oie, S.; VanStone, J.C.; Briggs, W.A. and Levy, G.: Pharmacokinetics of acetaminophen elimination by anephric patients. Journal of Pharmacology and Experimental Therapeutics 156: 570–578 (1976).

    Google Scholar 

  • Mabee, T.M.; Meyer, P.; DenBesten, L. and Mason, E.E.: The mechanism of increased gallstone formation in obese human subjects. Surgery 79: 460–468 (1976).

    PubMed  CAS  Google Scholar 

  • Madura, J.A.; Loomis, R.C.; Harris, R.A.; Grosfeld, J. and Tompkins, R.K.: Relationship of bile lithogenicity in man. Annals of Surgery 189: 106–111 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Marquardt, D.W.: An algorithm for least-squares estimation of non-linear parameters. Journal of the Society of Industrial and Applied Mathematics 11: 431–441 (1963).

    Article  Google Scholar 

  • Miller, M.S.; Gandolfi, A.J.; Vaughen, R.W. and Bentley, J.B.: Disposition of enflurane in obesity. Journal of Pharmacology and Experimental Therapeutics 215: 792–796 (1980).

    Google Scholar 

  • Ochs, H.R.; Greenblatt, D.J. and Bodem, G.: Single- and multipledose kinetics of intravenous digoxin. Clinical Pharmacology and Therapeutics 28: 340–345 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Peterson, V.P.: Body composition and fluid compartments in normal, obese, and underweight human subjects. Acta Medica Scandinavica 158: 103–115 (1957).

    Article  Google Scholar 

  • Savaia, R.A.; Lunn, J.N.; Mapleson, W.W.; Willis, B.A. and France, J.M.: Adiposity and the pharmacokinetics of halothane. Anaesthesia 32: 240–246 (1977).

    Article  Google Scholar 

  • Schwartz, S.N.; Pazin, G.J.; Lyon, J.A.; Ho, M. and Pasculle, A.W.: A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects. Journal of Infectious Disease 138: 499–505 (1978).

    Article  CAS  Google Scholar 

  • Smith, T.W. and Haber, E.: Digitalis (Little, Brown, Boston, Mass. 1974).

    Google Scholar 

  • Smith, T.W.; Butler, V.P. and Haber, E: Determination of the therapeutic and toxic serum digoxin concentrations by radioimmunoassay. New England Journal of Medicine 281: 1212–1216 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Society of Actuaries: Build and Blood Pressure Study, Vol. I and II (Society of Actuaries, Chicago, Ill. 1959).

  • Stokholm, K.H.: Increased glomerular filtration rate and adrenocortical function in obese women. International Journal of Obesity 4: 57–63 (1980).

    PubMed  CAS  Google Scholar 

  • Usanis, R.A.: NLIN-nonlinear least-squares estimate of parameters (Library Services Series Document No. LSR-089-1). Research Triangle Park, North Carolina, Triangle Universities Computation Center (1972).

    Google Scholar 

  • Van Itallie, T.B.: Obesity: Adverse effects on health and longevity. American Journal of Clinical Nutrition 32: 2723–2733 (1979).

    PubMed  Google Scholar 

  • Watson, P.E.; Watson, I.D. and Batt, R.D.: Total body water volumes for adult males and females estimated from simple anthropometric measurements. American Journal of Clinical Nutrition 33: 27–39 (1980).

    PubMed  CAS  Google Scholar 

  • Womersley, J.; Durnin, J.; Boddy, K. and Mahaffy, M.: Influence of muscular development, obesity, and age on the fat-free mass of adults. Journal of Applied Physiology 41: 273–279 (1976).

    Google Scholar 

  • Woo, E. and Greenblatt, D.J.: Pharmacokinetic and clinical implications of quinidine protein binding. Journal of Pharmaceutical Sciences 68: 466–470 (1979).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Pharmacology, Departments of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center Hospital, Boston, USA

    Darrell R. Abernethy & David J. Greenblatt

Authors
  1. Darrell R. Abernethy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David J. Greenblatt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abernethy, D.R., Greenblatt, D.J. Pharmacokinetics of Drugs in Obesity. Clin Pharmacokinet 7, 108–124 (1982). https://doi.org/10.2165/00003088-198207020-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198207020-00002

Keywords

Search

Navigation